NeoSpikeMix™ for Immunopeptidomics
In immunopeptidomics, the verification of neo-epitopes within short non-tryptic peptide sequences is still challenging due to limited sensitivity and specificity. LC-MS/MS measurement of ~170.000 synthetic peptides showed that more than 10% of the assigned spectra were not in agreement with the respective synthetic references with standard data analysis routines. These results highlight the urgent need for reference peptides to be used in immunopeptidomics such as JPT’s NeoSpikeMix™:
- Customized peptide libraries for immunopeptidomics
- References for MHC I and MHC II binding HLA peptides by mass spectrometry
- Fast and cheap access to reference peptides
- Increase accuracy of neo-epitope identification
Applications for NeoSpikeMix™ for Immunopeptidomics
- Mass spectrometry-based neo-epitope prioritization
- Neo-epitope identification
- HLA ligand identification and optimization
Benefits of NeoSpikeMix™ for Immunopeptidomics
- Hundreds or thousands of peptides within one week
- Low price
- Provides high sensitivity as needed for low abundance epitopes
- Light or stable isotope-labeled
Request a price for
NeoSpikeMix™
News Highlights
- References for Clinical Proteomics?
Try the NEW SpikeTides™_TQL PLUS! Quantified SIL Peptides that allow quantification immediately before the experiment
(Dec 2018) -
The Human Proteome Peptide Catalog
More than 400,000 validated reference peptides covering essentially all human proteins
(Apr 2018) -
Protein Interaction Screen on Peptide Matrix (PRISMA)
Assay to systematically explore protein-protein interactions, decode the influence of post-translational modifications or sequence diversity, compare cell states or map pathways
(March 2018)
Downloads
Quality Assurance
All production is performed according to ISO 9001:2015 standards